EQS — Adhoc: Cessation of operations and closure of the company

EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency Cessation of operations and closure of the company 24-Sep-2026 / 10:37 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by 1 EQS News — a service of 2 EQS Group. The issuer is solely responsible for the content of this announcement. ══════════════════════════════════════════════════════════════════════════ Korneuburg, Austria, 24^th September 2026 — Marinomed Biotech AG: Cessation of operations and closure of the company Marinomed Biotech AG announces that the administrator, Dr. Ulla Reisch, filed a motion to close the business during the court hearing on September 24, 2026. Consequently, the insolvency court ordered the closure of Marinomed Biotech AG’s business operations. It was not possible to ensure the continuation of the business because ongoing operations failed to yield the necessary positive results, a planned sale of licensing rights could not be concluded in time, and discussions with potential investors had been unsuccessful to date. The insolvency administrator will now initiate a sale of the company's assets. The company will provide updates o